Table 2.

Selectivity of pirtobrutinib in cell-based assays

KinasenPirtobrutinib IC50, mean ± SD, nMFold selectivity vs BTK Cell assay readout
BTK 0.66 ± 0.34 Competitive displacement of tracer 
TEC 70.46 ± 20.30 106.8 Competitive displacement of tracer 
BRK/PTK6 360.47 ± 198.56 546.2 Competitive displacement of tracer 
TXK >5000  >7600 Competitive displacement of tracer 
YES1 >5000  >7600 Competitive displacement of tracer 
CSK >5000  >7600 Competitive displacement of tracer 
FYN >5000  >7600 Competitive displacement of tracer 
ERBB4 >10 000  N/D Phosphorylation of C-terminal tail 
MEK1/MEK2 12 600 ± 2400 N/D Phosphorylation of ERK1/2 (HCT116 cells) 
MEK1/MEK2 3790 ± 1310 N/D Phosphorylation of ERK1/2 (A375 cells) 
KinasenPirtobrutinib IC50, mean ± SD, nMFold selectivity vs BTK Cell assay readout
BTK 0.66 ± 0.34 Competitive displacement of tracer 
TEC 70.46 ± 20.30 106.8 Competitive displacement of tracer 
BRK/PTK6 360.47 ± 198.56 546.2 Competitive displacement of tracer 
TXK >5000  >7600 Competitive displacement of tracer 
YES1 >5000  >7600 Competitive displacement of tracer 
CSK >5000  >7600 Competitive displacement of tracer 
FYN >5000  >7600 Competitive displacement of tracer 
ERBB4 >10 000  N/D Phosphorylation of C-terminal tail 
MEK1/MEK2 12 600 ± 2400 N/D Phosphorylation of ERK1/2 (HCT116 cells) 
MEK1/MEK2 3790 ± 1310 N/D Phosphorylation of ERK1/2 (A375 cells) 

N/D, not determined; n, number of samples; SD, standard deviation.

Fold selectivity values vs BTK were calculated for those kinases assayed in the NanoBRET competitive displacement assay.

When data values did not fit an IC50 curve, the top dose tested was used for estimating mean.

Close Modal

or Create an Account

Close Modal
Close Modal